CAS: 501121-34-2 - [(3S,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoyl]oxysodium
Formula:C33H34FN2NaO5
InChI:InChI=1/C33H35FN2O5.Na/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40;/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40);/q;+1/p-1/t26-,27-;/m0./s1
- Synonyms:
- S,S-Atorvastatin
Atorvastatin EP Impurity E Sodium Salt (Atorvastatin USP Related Compound E Sodium Salt, ent-Atorvastatin Sodium Salt)
Formula:
C33H34FN2O5·Na
Molecular weight:
557.65 22.99
Ref: 4Z-A-12123
10mg | To inquire | |
20mg | 2,007.00 € | |
25mg | To inquire | |
30mg | 2,590.00 € | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Monday 6 May 2024
Atorvastatin EP Impurity E (Atorvastatin USP Related Compound E (Free Form), ent-Atorvastatin)
CAS:501121-34-2
Formula:
C33H35FN2O5
Molecular weight:
558.65
Ref: 4Z-A-1220
10mg | To inquire | |
20mg | 2,014.00 € | |
25mg | To inquire | |
30mg | 2,598.00 € | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Monday 6 May 2024
(3S,5S)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic Acid Calcium Salt (ent-Atorvastatin Calcium Salt)
Controlled ProductFormula:
C33H34FN2O5·Ca
Color and Shape:
White Solid
Molecular weight:
1155.34
Ref: 86-MM0400.28-0025
25mg | 828.00 € |
Estimated delivery in United States, on Monday 6 May 2024
(3S,5S)-Atorvastatin sodium salt
CAS:501121-34-2
Atorvastatin is a statin drug that inhibits the enzyme HMG-CoA reductase, which is responsible for …
Formula:
C33H34FN2NaO5
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
580.62 g/mol
Ref: 3D-IA18023
1mg | 101.00 € | |
2mg | 144.00 € | |
5mg | 260.00 € | |
10mg | 355.00 € | |
25mg | 677.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024